google_counter
Prostate Cancer Treatment with Lutetium-177 PSMA (284543) | University Hospital Tuebingen - BookingHealth
{"translation_price":"50","translation_doc_price":"40","child_coefficient":"1.1","transfer_price":"2.00","transfer_price_vip":"5.00","constant_transfer_price_vip":350,"constant_transfer_price":150,"constant_transfer_distanse":60,"type":"treatment","program_full_story":"<ul>\n\t<li>Initial presentation in the clinic<\/li>\n\t<li>history taking<\/li>\n\t<li>general clinical examination<\/li>\n\t<li>laboratory tests:\n\t<ul>\n\t\t<li>complete blood count<\/li>\n\t\t<li>biochemical analysis of blood<\/li>\n\t\t<li>urinalysis<\/li>\n\t\t<li>TSH-basal, fT3, fT4<\/li>\n\t\t<li>PSA blood test<\/li>\n\t\t<li>tests for urogenital infections<\/li>\n\t\t<li>indicators of inflammation<\/li>\n\t\t<li>indicators of blood coagulation<\/li>\n\t<\/ul>\n\t<\/li>\n\t<li>ultrasound scan of the urogenital system<\/li>\n\t<li>renal scintigraphy<\/li>\n\t<li>PSMA PET-CT (if indicated)<\/li>\n\t<li>PSMA treatment<\/li>\n\t<li>full body scintigraphy after 24 hours<\/li>\n\t<li>full body scintigraphy after 48&nbsp;hours<\/li>\n\t<li>symptomatic treatment<\/li>\n\t<li>cost of essential medicines<\/li>\n\t<li>nursing services<\/li>\n\t<li>elaboration of further recommendations<\/li>\n\t<li>stay in the hospital with full board&nbsp;<\/li>\n\t<li>accommodation in a room with 2 beds<\/li>\n<\/ul>\n<div class=\"program_how_program_going mt-4\"><h4>How program is carried out<\/h4><p style=\"text-align:justify\"><strong>During the first visit<\/strong>,&nbsp;the doctor will carry out a general physical examination and go through the results of your previous laboratory and instrumental tests. After that, you will undergo any necessary additional tests, such as an assessment of your liver and kidney function, a scintigraphy of your skeleton and salivary glands, a PSMA PET\/CT (additional cost). This will allow the doctor to calculate your individual dosage of the radionuclide.<\/p>\n\n<p style=\"text-align:justify\"><strong>PSMA therapy with Lutetium-177<\/strong>&nbsp;is carried out via intravenous administration of a solution containing the radioactive isotope, Lutetium-177. The solution is injected through a catheter. This is a short procedure, as the infusion usually takes no more than 20 minutes.<\/p>\n\n<p style=\"text-align:justify\">During the procedure, you will need to apply cooling bags to your salivary glands, as Lutetium-177 partially accumulates in the salivary glands, affecting their function and causing a dry mouth. You will also receive intravenous saline solutions to protect your kidneys.<\/p>\n\n<p style=\"text-align:justify\">After the infusion of Lutetium-177, you will stay in a specially equipped (radiation-shielded) ward for 48 hours. The drug is quickly excreted by the kidneys, and after 48 hours you will no longer be dangerous to others. During these 48 hours, you can read, use a mobile phone, tablet or computer &ndash; none of these devices will be a source of radiation in the future.<\/p>\n\n<p style=\"text-align:justify\"><strong>Follow-up examinations<\/strong>&nbsp;include whole-body scintigraphy and computed tomography in 24 hours, and then again 48 hours after the procedure.<\/p>\n<\/div><div class=\"program_required_documents mt-4\"><h4>Required documents<\/h4><ul>\n\t<li style=\"text-align: justify;\">Medical records<\/li>\n\t<li style=\"text-align: justify;\">MRI\/CT scan (not older than 3 months)<\/li>\n\t<li style=\"text-align: justify;\">Biopsy results (if available)<\/li>\n<\/ul>\n<\/div>","program_full_story_crm":"<ul>\n\t<li>Initial presentation in the clinic<\/li>\n\t<li>history taking<\/li>\n\t<li>general clinical examination<\/li>\n\t<li>laboratory tests:\n\t<ul>\n\t\t<li>complete blood count<\/li>\n\t\t<li>biochemical analysis of blood<\/li>\n\t\t<li>urinalysis<\/li>\n\t\t<li>TSH-basal, fT3, fT4<\/li>\n\t\t<li>PSA blood test<\/li>\n\t\t<li>tests for urogenital infections<\/li>\n\t\t<li>indicators of inflammation<\/li>\n\t\t<li>indicators of blood coagulation<\/li>\n\t<\/ul>\n\t<\/li>\n\t<li>ultrasound scan of the urogenital system<\/li>\n\t<li>renal scintigraphy<\/li>\n\t<li>PSMA PET-CT (if indicated)<\/li>\n\t<li>PSMA treatment<\/li>\n\t<li>full body scintigraphy after 24 hours<\/li>\n\t<li>full body scintigraphy after 48&nbsp;hours<\/li>\n\t<li>symptomatic treatment<\/li>\n\t<li>cost of essential medicines<\/li>\n\t<li>nursing services<\/li>\n\t<li>elaboration of further recommendations<\/li>\n\t<li>stay in the hospital with full board&nbsp;<\/li>\n\t<li>accommodation in a room with 2 beds<\/li>\n<\/ul>\n<div class=\"program_how_program_going mt-4\"><h4>How program is carried out<\/h4><p style=\"text-align:justify\"><strong>During the first visit<\/strong>,&nbsp;the doctor will carry out a general physical examination and go through the results of your previous laboratory and instrumental tests. After that, you will undergo any necessary additional tests, such as an assessment of your liver and kidney function, a scintigraphy of your skeleton and salivary glands, a PSMA PET\/CT (additional cost). This will allow the doctor to calculate your individual dosage of the radionuclide.<\/p>\n\n<p style=\"text-align:justify\"><strong>PSMA therapy with Lutetium-177<\/strong>&nbsp;is carried out via intravenous administration of a solution containing the radioactive isotope, Lutetium-177. The solution is injected through a catheter. This is a short procedure, as the infusion usually takes no more than 20 minutes.<\/p>\n\n<p style=\"text-align:justify\">During the procedure, you will need to apply cooling bags to your salivary glands, as Lutetium-177 partially accumulates in the salivary glands, affecting their function and causing a dry mouth. You will also receive intravenous saline solutions to protect your kidneys.<\/p>\n\n<p style=\"text-align:justify\">After the infusion of Lutetium-177, you will stay in a specially equipped (radiation-shielded) ward for 48 hours. The drug is quickly excreted by the kidneys, and after 48 hours you will no longer be dangerous to others. During these 48 hours, you can read, use a mobile phone, tablet or computer &ndash; none of these devices will be a source of radiation in the future.<\/p>\n\n<p style=\"text-align:justify\"><strong>Follow-up examinations<\/strong>&nbsp;include whole-body scintigraphy and computed tomography in 24 hours, and then again 48 hours after the procedure.<\/p>\n<\/div>","is_ambulant":"0","bh_fee":"0","only_for_children":"2","no_service":"0","with_prepayment":"1","show_calculator":"1","paket_type":"1","btn_type":"2","clinic_icon":"6000458b4633b.jpg","city":"Tuebingen","clinic_site":"www.medizin.uni-tuebingen.de","department_recommend":"1","country":"Germany","country_id":"1","clinic_name":"University Hospital Tuebingen","cinic_name":"University Hospital Tuebingen","department_id":"1655","duration":"5","direction":"Nuclear Medicine","min_duration":0,"clinic_id":"533","paketPrice":7800,"paket":"<ul>\n <li>Interpreter up to 17 hours<\/li>\n <li>Translation up to 10 pages<\/li>\n <li>Visa support<\/li>\n\n \n<\/ul>","title":"Prostate Cancer Treatment with Lutetium-177 PSMA","price":{"val":23153.059999999998,"type":"val"},"price_surcharge":0,"price_surcharge_clear":0,"extra_service_clinic":[{"id":"need_to_use_head_doctor","title":"Treatment by leading experts","type":"val","val":"4502.46","req":0},{"id":"vip_person_room","title":"VIP room (whole period)","parent":"duration","type":"count_val","val":"80.00"},{"id":"1_person_room","title":" Single room (whole period)","parent":"duration","type":"count_val","val":"160.00"},{"id":"2_person_room","title":" double room (whole period)","parent":"duration","type":"count_val","val":"71.00"},{"id":"attendant_place","title":"Accommodation for the accompanying person ","parent":"duration","type":"count_val","val":"90.00"}],"extra_service":[],"translation_hours":"0","translation_doc_count":null,"roads":[{"id":"19","distance":"33","airport_title":"Stuttgart"},{"id":"2","distance":"244","airport_title":"Munich"},{"id":"6","distance":"262","airport_title":"Frankfurt a.M."}],"pakets":[],"lang":{"day":"Day","days":"days","ambulatory":"Outpatient","stationaryProgram":"Inpatient"}}

Prostate Cancer Treatment with Lutetium-177 PSMA in University Hospital Tuebingen

University Hospital Tuebingen

Tuebingen, Germany
Program id # 284543
Doctor photo
Prof. Dr. med. Christian la Fougère
Department of Nuclear Medicine and Clinical Imaging Diagnostics
Specialized in: nuclear medicine, clinical imaging diagnostics

The program includes:

  • Initial presentation in the clinic
  • history taking
  • general clinical examination
  • laboratory tests:
    • complete blood count
    • biochemical analysis of blood
    • urinalysis
    • TSH-basal, fT3, fT4
    • PSA blood test
    • tests for urogenital infections
    • indicators of inflammation
    • indicators of blood coagulation
  • ultrasound scan of the urogenital system
  • renal scintigraphy
  • PSMA PET-CT (if indicated)
  • PSMA treatment
  • full body scintigraphy after 24 hours
  • full body scintigraphy after 48 hours
  • symptomatic treatment
  • cost of essential medicines
  • nursing services
  • elaboration of further recommendations
  • stay in the hospital with full board 
  • accommodation in a room with 2 beds

How program is carried out

During the first visit, the doctor will carry out a general physical examination and go through the results of your previous laboratory and instrumental tests. After that, you will undergo any necessary additional tests, such as an assessment of your liver and kidney function, a scintigraphy of your skeleton and salivary glands, a PSMA PET/CT (additional cost). This will allow the doctor to calculate your individual dosage of the radionuclide.

PSMA therapy with Lutetium-177 is carried out via intravenous administration of a solution containing the radioactive isotope, Lutetium-177. The solution is injected through a catheter. This is a short procedure, as the infusion usually takes no more than 20 minutes.

During the procedure, you will need to apply cooling bags to your salivary glands, as Lutetium-177 partially accumulates in the salivary glands, affecting their function and causing a dry mouth. You will also receive intravenous saline solutions to protect your kidneys.

After the infusion of Lutetium-177, you will stay in a specially equipped (radiation-shielded) ward for 48 hours. The drug is quickly excreted by the kidneys, and after 48 hours you will no longer be dangerous to others. During these 48 hours, you can read, use a mobile phone, tablet or computer – none of these devices will be a source of radiation in the future.

Follow-up examinations include whole-body scintigraphy and computed tomography in 24 hours, and then again 48 hours after the procedure.

Required documents

  • Medical records
  • MRI/CT scan (not older than 3 months)
  • Biopsy results (if available)

Service

Price from:
Type of program :
Price for 1 day:
Expected duration of the program:
The minimum duration of the program:
Select

You may also book:

Hospital directly:
Saving:
Guarantee BookingHealth Price from:

About the department

The Department of Nuclear Medicine and Clinical Imaging Diagnostics at the University Hospital Tuebingen offers the full range of radioisotope diagnostics and treatment of various diseases. The department is headed by Prof. Dr. med. Christian la Fougère.

Both classical diagnostic methods, for example, scintigraphy, SPECT and innovative hybrid techniques, for example, PET-CT, PET-MRT, SPECT-CT are available in the department, which allow to detect metabolic changes at the early stages of various diseases, as well as their localization in the human body. In addition, the department's doctors specialize in radiotherapy for the treatment of oncopathologies.

The diagnostic range of the department covers:

  • Scintigraphy
    • Osteoscintigraphy (skeleton scintigraphy)
    • Thyroid scintigraphy
    • Preoperative marking of the sentinel lymph nodes
    • Renal scintigraphy
    • Scintigraphy in inflammatory processes
    • Ventilation/perfusion lung scintigraphy
    • Myocardial scintigraphy
    • Brain scintigraphy (DaTSCAN)
    • Liver scintigraphy
    • Parathyroid scintigraphy
    • Scintigraphy for the determination of the degree of gastric emptying
    • Scintigraphy for the determination of the hemorrhage source
    • Lymphoscintigraphy
  • SPECT-CT
  • PET-MRI
  • PET-CT
  • Thyroid diagnostics (within the specialized outpatient clinic)
    • Ultrasound examinations
    • PET-CT
    • Fine-needle aspiration biopsy
  • Other diagnostic methods

The therapeutic options of the department:

  • Radiation therapy for the treatment of benign and malignant diseases of the thyroid gland
  • Selective internal radiation therapy for the treatment of liver tumors and metastases
  • Peptide receptor radionuclide therapy for the treatment of malignant neuroendocrine tumors
  • Lu-177 PSMA radionuclide therapy for the treatment of prostate cancer and its metastases
  • Therapy for the treatment of prostate cancer and metastasis
  • MIBG therapy for the treatment of neuroendocrine tumors
  • Samarium radiation therapy for the treatment of certain forms of bone cancer
  • Other types of radiation therapy

Curriculum vitae

Professional Career

  • 2017 and up to now, Deputy Managing Director, Department of Radiology, University Hospital Tuebingen.
  • 2013 and up to now, Full Professor and Director, Department of Nuclear Medicine and Clinical Imaging Diagnostics, University Hospital Tuebingen.
  • 2010 Associate Professor of Nuclear Medicine, Ludwig Maximilian University of Munich.
  • 2009 - 2013 Chief of the Section of Neurological and Neuro-Oncological Imaging, Department of Nuclear Medicine, Ludwig Maximilian University of Munich.
  • 2008 - 2009 Research Fellow, Brain Imaging Centre, Montréal Neurological Institute, McGill-University, Canada.
  • 2003 Doctor of Medicine, Ludwig Maximilian University of Munich.
  • 2002 - 2008 Resident, Department of Nuclear Medicine, Ludwig Maximilian University of Munich.
  • 2002 German Medical License, Ludwig Maximilian University of Munich.
  • 2001 - 2002 Elective, Department of Internal Medicine, Hôpital Européen Georges Pompidou, University of Paris, and at the Departments of Surgery and Radiology, Ludwig Maximilian University of Munich.

Scholarships, Awards and Administrative Functions

  • 2018 Executive Board Member, German Society of Nuclear Medicine (DGN).
  • 2017 Program Chair, German Nuclear Imaging Congress.
  • 2016 Spokesman, Committee on Multi-Center-Trials of the German Society of Nuclear Medicine (DGN).
  • 2015 Board Member, Comprehensive Cancer Center Tuebingen-Stuttgart.
  • 2015 Member, Editorial Board of the Nuclear Medicine Journal.
  • 2015 Member, Editorial Board, Der Nukelarmediziner.
  • 2011 Committee Member, Neuro-Nuclear Medicine Board of the German Society of Nuclear Medicine.
  • 2008 - 2009 Scholarship from German Research Foundation (DFG).
  • 2008 Scholarship from the Bavarian Research Alliance (Bayerische Forschungsallianz).
  • 2005 Scholarship from Ludwig Maximilian University of Munich.

Photo of the doctor: (c) Universitätsklinikum Tübingen 


About hospital

According to the prestigious medical publication Focus, the University Hospital Tuebingen ranks among the top five German hospitals! 

The hospital was founded in 1805, therefore it is proud of its long history, unique experience, and outstanding achievements in the field of medical care, as well as research and teaching activities. Nowadays, it is one of the most advanced medical institutions, which provides a wide range of general and highly specialized medical services. The hospital combines the state-of-art medical technologies in the field of diagnostics and the very latest treatment methods of a wide range of diseases.

The hospital has 17 specialized departments, which cover almost all fields of modern medicine and contribute to the top-class medical service in Germany. It treats about 367,000 outpatients and 74,000 inpatients annually. This testifies to the high authority of the hospital at the national and international medical arena. This is the first German hospital, which confirmed the high quality of healthcare and the effectiveness of service with a KTQ certification (in 2009).

Photo: (с) depositphotos

Accommodation in hospital

Patients rooms

The patients of the University Hospital Tuebingen live in comfortable single and double rooms with an ensuite bathroom equipped with a shower and toilet. The beds in the patient rooms are equipped with orthopedic mattresses that promote good and full sleep. There is a TV in the room, and it is also possible to connect a smartphone or laptop to the Internet. In addition, there is enough space in the patient room to receive 2-3 guests without inconvenience for the second patient.

The enhanced-comfort rooms include a hairdryer, heated towel rail, a large mirror, a direct dial telephone, a flat-screen satellite TV, a writing desk, free Internet access, a mini-bar and a refrigerator.

Meals and Menus

The patients of the hospital are offered tasty and healthy three meals a day: breakfast, lunch and dinner. Breakfast is served as a buffet, while for lunch and dinner there is a choice of several menus. Also, if desired, the patient will be provided with an individual menu. There are several cafes and cafeterias on the territory of the hospital, where one can have a tasty meal or enjoy a cup of coffee, tea and dessert.

Further details

Standard rooms include:

Toilet
Shower
Wi-Fi
TV

Religion

Religious services are available upon request.

Accompanying person

During the inpatient program, an accompanying person can stay with you in a patient room or in a hotel of your choice.

Hotel

During the outpatient program, you can stay in a hotel of your choice. Our managers will help you choose the most suitable option for you.